Recent collaborations and financing deals involving small-mid biotechs and big pharmaceutical firms are focused on next-generation cancer therapies. Learn about new cancer therapies in development, and the focus on new classes of drugs from oncolytic viruses to radiotherapeutics, which are in stark contrast to CAR-T cell–based therapies.
Moderator
Speakers
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
